| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1196.97/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.97 |
| Version | 20190511 |
| Status | active |
| Date | 2019-05-11T01:00:10-04:00 |
| Name | CPICRxNORMAtomoxetineSCDG |
| Title | CPIC RxNORM atomoxetine SCDG |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Description | We have NOT excluded any dose forms (such as topical), at this time, even though in some cases topical medications may not be subject to the same drug-gene interactions that are seen with systemically administered medications. Elimu OID : 2019.05.14.10.54 |
| Purpose | (Clinical Focus: his value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having atomoxetine as an ingredient.),(Data Element Scope: None),(Inclusion Criteria: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having atomoxetine as an ingredient.),(Exclusion Criteria: None) |
No resources found
| CodeSystem | |
http://www.nlm.nih.gov/research/umls/rxnorm  | RxNorm |
| http://www.nlm.nih.gov/research/umls/rxnorm | RxNorm |
FHIR{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1196.97",
"meta" : {
"versionId" : "5",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "Elimu Informatics Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-02-14"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2019-05-11"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.97",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1196.97"
}
],
"version" : "20190511",
"name" : "CPICRxNORMAtomoxetineSCDG",
"title" : "CPIC RxNORM atomoxetine SCDG",
"status" : "active",
"experimental" : false,
"date" : "2019-05-11T01:00:10-04:00",
"publisher" : "Elimu Informatics Steward",
"description" : "We have NOT excluded any dose forms (such as topical), at this time, even though in some cases topical medications may not be subject to the same drug-gene interactions that are seen with systemically administered medications.\nElimu OID : 2019.05.14.10.54",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: his value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having atomoxetine as an ingredient.),(Data Element Scope: None),(Inclusion Criteria: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having atomoxetine as an ingredient.),(Exclusion Criteria: None)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "1158282",
"display" : "atomoxetine Oral Product"
},
{
"code" : "1158283",
"display" : "atomoxetine Pill"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:b0a4e40b-de1f-407b-b9c6-00418fa37c5e",
"timestamp" : "2024-12-10T07:38:10-05:00",
"total" : 2,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1158282",
"display" : "atomoxetine Oral Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1158283",
"display" : "atomoxetine Pill"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.